141 related articles for article (PubMed ID: 9493284)
1. Loss of T-cell cytotoxic responses in the course of HIV-1 infection.
Zerhouni B; Sanhadji K; Touraine JL
Thymus; 1997; 24(4):203-19. PubMed ID: 9493284
[TBL] [Abstract][Full Text] [Related]
2. HIV-specific cytotoxic T lymphocytes in seropositive individuals.
Walker BD; Chakrabarti S; Moss B; Paradis TJ; Flynn T; Durno AG; Blumberg RS; Kaplan JC; Hirsch MS; Schooley RT
Nature; 1987 Jul 23-29; 328(6128):345-8. PubMed ID: 3496541
[TBL] [Abstract][Full Text] [Related]
3. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD
AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847
[TBL] [Abstract][Full Text] [Related]
4. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
Ho HN; Hultin LE; Mitsuyasu RT; Matud JL; Hausner MA; Bockstoce D; Chou CC; O'Rourke S; Taylor JM; Giorgi JV
J Immunol; 1993 Apr; 150(7):3070-9. PubMed ID: 8454874
[TBL] [Abstract][Full Text] [Related]
5. Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes.
Kundu SK; Merigan TC
AIDS; 1992 Jul; 6(7):643-9. PubMed ID: 1354446
[TBL] [Abstract][Full Text] [Related]
6. Cultured blood dendritic cells retain HIV-1 antigen-presenting capacity for memory CTL during progressive HIV-1 infection.
Fan Z; Huang XL; Zheng L; Wilson C; Borowski L; Liebmann J; Gupta P; Margolick J; Rinaldo C
J Immunol; 1997 Nov; 159(10):4973-82. PubMed ID: 9366424
[TBL] [Abstract][Full Text] [Related]
7. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.
van Baalen CA; Guillon C; van Baalen M; Verschuren EJ; Boers PH; Osterhaus AD; Gruters RA
Eur J Immunol; 2002 Sep; 32(9):2644-52. PubMed ID: 12207349
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.
Langlade-Demoyen P; Ngo-Giang-Huong N; Ferchal F; Oksenhendler E
J Clin Invest; 1994 Mar; 93(3):1293-7. PubMed ID: 8132769
[TBL] [Abstract][Full Text] [Related]
9. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex.
Jassoy C; Johnson RP; Navia BA; Worth J; Walker BD
J Immunol; 1992 Nov; 149(9):3113-9. PubMed ID: 1383338
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of natural killer cell activities from normal donors and AIDS patients by envelope peptides from human immunodeficiency virus type I.
Nair MP; Schwartz SA
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):969-79. PubMed ID: 9449529
[TBL] [Abstract][Full Text] [Related]
11. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
Tomiyama H; Miwa K; Shiga H; Moore YI; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
J Immunol; 1997 May; 158(10):5026-34. PubMed ID: 9144523
[TBL] [Abstract][Full Text] [Related]
12. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
Borghan MA; Oka S; Takiguchi M
Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
[TBL] [Abstract][Full Text] [Related]
13. Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children.
Buseyne F; Chaix ML; Fleury B; Manigart O; Burgard M; Blanche S; Rouzioux C; Rivière Y
Virology; 1998 Oct; 250(2):316-24. PubMed ID: 9792842
[TBL] [Abstract][Full Text] [Related]
14. Conserved CTL epitopes shared between HIV-infected human long-term survivors and chimpanzees.
Balla-Jhagjhoorsingh SS; Koopman G; Mooij P; Haaksma TG; Teeuwsen VJ; Bontrop RE; Heeney JL
J Immunol; 1999 Feb; 162(4):2308-14. PubMed ID: 9973508
[TBL] [Abstract][Full Text] [Related]
15. Rat cytotoxic T lymphocytes against human T-lymphotropic virus type 1-infected cells recognize gag gene and env gene encoded antigens.
Noguchi Y; Tateno M; Kondo N; Yoshiki T; Shida H; Nakayama E; Shiku H
J Immunol; 1989 Dec; 143(11):3737-42. PubMed ID: 2479689
[TBL] [Abstract][Full Text] [Related]
16. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).
Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC
J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 reverse transcriptase-specific CTL against conserved epitopes do not protect against progression to AIDS.
van der Burg SH; Klein MR; Pontesilli O; Holwerda AM; Drijfhout JW; Kast WM; Miedema F; Melief CJ
J Immunol; 1997 Oct; 159(7):3648-54. PubMed ID: 9317165
[TBL] [Abstract][Full Text] [Related]
18. Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion.
Connick E; Schlichtemeier RL; Purner MB; Schneider KM; Anderson DM; MaWhinney S; Campbell TB; Kuritzkes DR; Douglas JM; Judson FN; Schooley RT
J Infect Dis; 2001 Dec; 184(11):1465-9. PubMed ID: 11709791
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of interleukin-7 receptor may generate loss of cytotoxic T cell response in human immunodeficiency virus type 1 infection.
Carini C; McLane MF; Mayer KH; Essex M
Eur J Immunol; 1994 Dec; 24(12):2927-34. PubMed ID: 7805718
[TBL] [Abstract][Full Text] [Related]
20. Clustered epitopes within the Gag-Pol fusion protein DNA vaccine enhance immune responses and protection against challenge with recombinant vaccinia viruses expressing HIV-1 Gag and Pol antigens.
Bolesta E; Gzyl J; Wierzbicki A; Kmieciak D; Kowalczyk A; Kaneko Y; Srinivasan A; Kozbor D
Virology; 2005 Feb; 332(2):467-79. PubMed ID: 15680412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
